about
A novel vasopressin-induced transcript promotes MAP kinase activation and ENaC downregulation.Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathwaysDuration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunctionSchisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signalingA possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.siRNA-based therapy ameliorates glomerulonephritisMig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathwaysNicotine signaling and progression of chronic kidney disease in smokers.Sustained oxidative stress causes late acute renal failure via duplex regulation on p38 MAPK and Akt phosphorylation in severely burned rats.High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.Physiology and pathology of endothelin-1 in renal mesangium.Increased unbound retinol-binding protein 4 concentration induces apoptosis through receptor-mediated signaling.G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease.Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathwayActivation of the succinate receptor GPR91 in macula densa cells causes renin release.Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia.FAK contributes to proteinuria in hypercholesterolaemic rats and modulates podocyte F-actin re-organization via activating p38 in response to ox-LDLNef as a Proliferative Factor for Kidney Epithelial Cells in HIV-Associated Nephropathy.ALL-TRANS-RETINOIC ACID-MEDIATED CYTOPROTECTION IN RENAL EPITHELIAL CELLS IS COUPLED TO p-ERK ACTIVATION IN A ROS-INDEPENDENT MANNER.Environmental hyperosmolality regulates phospholipid biosynthesis in the renal epithelial cell line MDCK.Amphotericin B-induced renal tubular cell injury is mediated by Na+ Influx through ion-permeable pores and subsequent activation of mitogen-activated protein kinases and elevation of intracellular Ca2+ concentration.Activator of G-protein Signaling 3 Controls Renal Epithelial Cell Survival and ERK5 Activation.Chronic hyperosmolarity mediates constitutive expression of molecular chaperones and resistance to injury.p38 MAPK mediates acid-induced transcription of PEPCK in LLC-PK(1)-FBPase(+) cells.The roles of p38MAPK and caspase-3 in DADS-induced apoptosis in human HepG2 cellsExpression of phosphorylated extracellular signal-regulated kinase in rat kidneys exposed to high +GzLoss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.LPA is a novel lipid regulator of mesangial cell hexokinase activity and HKII isoform expression.Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells.Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells.Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: role of ERK1/2 pathway.Exposures of male rats to environmental chemicals [bisphenol A and di (2-ethylhexyl) phthalate] affected expression of several proteins in the developing epididymis.Beneficial Effects of Bioactive Compounds in Mulberry Fruits against Cisplatin-Induced Nephrotoxicity.Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.
P2860
Q24534880-01080B83-6DBD-41C3-9228-088CD4773520Q24563306-FF119457-ABFA-4CCB-9B12-9818542B177CQ24804200-CA0AB084-6AF8-4B85-9D77-AE16D5A9E722Q28543891-7D863C6A-AECE-45F0-8774-BF8D387E40C5Q30445038-291DF30B-8487-4993-8F29-95C61B3E7D62Q33748522-483FC4F3-7F5A-41B1-91F3-5BB678FE3895Q34138372-78A4F2C4-BECA-49AC-ACFE-F95FB83A6B9AQ34360219-950E32BD-8D6B-458F-8055-AE51B53AEDC1Q34563327-DEBE3E17-6989-4DD3-A376-78D67A7CA933Q34987778-76C07097-A399-4218-A646-B83F81015068Q35211305-3A54B216-56FB-498F-8EC4-983FE432354CQ35879928-48676C52-9599-4505-81C7-4715169E41C2Q36504457-B1DA8D71-FB40-460D-A611-7617F840B9B3Q36942409-878B0686-164C-400E-BF52-F682ACF0A98FQ37181984-54D167C4-9DE5-492D-AB59-1359C70F5833Q37363311-E0B13D3C-867F-44C6-B68C-5F8AC814C624Q37662913-849D23F5-741A-4A44-873C-2DC3A7C84B6DQ38260894-3508E087-1763-4987-BCC1-CA1B1618BB82Q38646116-05DB0455-FE24-4832-983D-3A993FFADDE8Q39220541-B443ACC2-7740-47B6-9987-710E31582335Q39896114-848A0F8C-3C72-4302-90ED-2D1B56201A39Q40159153-47C150DC-B199-4A31-BF49-E569CAFCF97DQ40693295-AA417D56-2480-4515-B63E-7591A636D1E2Q40705683-E65DD1FB-AD72-440A-A3E2-34642E05567DQ41344483-24A9B891-BDB5-4684-A73C-7A6B527BC497Q41926776-09DF1A98-9141-4569-AB8C-54639523B139Q42445655-5525EA8B-2BCE-46E3-AB8E-A9872A8F8FB1Q44058265-0F27272E-958A-425C-ADF8-6464A40DEDB1Q44185726-0407D08C-966E-4A86-9C4A-252455355C40Q44312278-86E84F66-EB98-4A51-8AA1-AF92259BAA29Q44636790-0F58766B-3659-4878-8382-463BFF1ECE02Q47244990-98DBEF80-E67A-48BC-9520-CBFDB606BEF3Q54966942-398FFF9F-082A-4864-87BF-D9C4FAC53DF9Q55207759-A69563B0-516E-4C13-8E37-50930373B78B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
MAPK signaling and the kidney.
@ast
MAPK signaling and the kidney.
@en
MAPK signaling and the kidney.
@nl
type
label
MAPK signaling and the kidney.
@ast
MAPK signaling and the kidney.
@en
MAPK signaling and the kidney.
@nl
prefLabel
MAPK signaling and the kidney.
@ast
MAPK signaling and the kidney.
@en
MAPK signaling and the kidney.
@nl
P2093
P2860
P1476
MAPK signaling and the kidney.
@en
P2093
P2860
P304
P356
10.1152/AJPRENAL.2000.279.4.F593
P577
2000-10-01T00:00:00Z